• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by East Resources Acquisition Company (Amendment)

    10/20/23 4:37:06 PM ET
    $ERES
    Investment Managers
    Finance
    Get the next $ERES alert in real time by email
    SC 13D/A 1 d452450dsc13da.htm SC 13D/A SC 13D/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)

     

     

    Abacus Life, Inc.

    (Name of Issuer)

    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)

    00258Y104

    (CUSIP Number)

    Jay Jackson

    c/o Abacus Life, Inc.

    2101 Park Center Drive, Suite 170

    Orlando, Florida 32835

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    October 13, 2023

    (Date of Event Which Requires Filing of this Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

     

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240. 13d-7 for other parties to whom copies are to be sent.

     

     

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on following pages)

     

     

     


    CUSIP No. 00258Y104       13D

     

     1   

     Name of Reporting Persons

     

     Jay Jackson

     2  

     Check the Appropriate Box if a Member of a Group

     (a) ☐  (b) ☐

     

     3  

     SEC Use Only

     

     4  

     Source of Funds

     

     OO

     5  

     Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

     

     ☐

     6  

     Citizenship or Place of Organization

     

     United States of America

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

     

        7   

     Sole Voting Power

     

     12,593,250

        8  

     Shared Voting Power

     

     0

        9  

     Sole Dispositive Power

     

     12,593,250

       10  

     Shared Dispositive Power

     

     0

    11   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     12,593,250

    12  

     Check if the Aggregate Amount in Row (11) Excludes Certain Shares

     

     ☐

    13  

     Percent of Class Represented by Amount in Row (11)

     

     20.0%

    14  

     Type of Reporting Person

     

     IN

     

     

     

    2


    CUSIP No. 00258Y104       13D

     

    Item 1.

    Security and Issuer

    This statement relates to the common stock, par value $0.0001 per share (the “Common Stock”), of Abacus Life, Inc., a Delaware corporation (the “Issuer”). The Issuer’s principal executive offices are located at 2101 Park Center Drive, Suite 170, Orlando, Florida 32835.

     

    Item 2.

    Identity and Background

     

      (a)

    This statement is filed by Jay Jackson (the “Filer”).

     

      (b)

    The business address for the Filer is c/o Abacus Life, Inc., 2101 Park Center Drive, Suite 170, Orlando, Florida 32835

     

      (c)

    Jay Jackson is Chairman and Chief Executive Officer of the Issuer. The business address for the Issuer is 12101 Park Center Drive, Suite 170, Orlando, Florida 32835.

     

      (d)

    The Filer has not during the last five years been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

     

      (e)

    The Filer has not during the last five years been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violations with respect to such laws.

     

      (f)

    The Filer is citizen of the United States of America.

     

    Item 3.

    Source and Amount of Funds or Other Consideration

    The shares of Common Stock described herein were acquired at the closing of the business combination pursuant to the Agreement and Plan of Merger, as amended (the “Merger Agreement”), as described in the Issuer’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on June 5, 2023, as supplemented, the reporting person received Common Stock of the Issuer as consideration for the common units of Longevity Market Assets, LLC and Abacus Settlements, LLC. On October 13, 2023, a transfer of 700,500 shares of Common Stock was made by the Reporting Person to East Sponsor, LLC to reflect the intended allocation of shares of Common Stock among the parties to the Merger Agreement.


    CUSIP No. 00258Y104       13D

     

    Item 4.

    Purpose of Transaction.

    Item 4 of Schedule 13D is hereby amended by adding the following:

    On October 13, 2023, a transfer of 700,500 shares of Common Stock was made by the Reporting Person to East Sponsor, LLC to reflect the intended allocation of shares of Common Stock among the parties to the Merger Agreement, thereby reducing Reporting Person’s stated beneficial ownership from 13,293,750 to 12,593,250 shares of Common Stock.

     

    Item 5.

    Interest in Securities of the Issuer.

    Item 5 of the Schedule 13D is hereby amended by adding the following:

     

      (a)

    As of the date hereof, Reporting Person beneficially owns 12,593,250 shares of Common Stock, which represents 20.0% of the Issuer’s 62,961,688 outstanding shares of Common Stock as of the date hereof.

     

      (b)

    Reporting Person beneficially owns 12,593,250 shares of Common Stock.

    (c)   On June 30, 2023, at the closing of the business combination pursuant to the Agreement and Plan of Merger, as amended (the “Merger Agreement”), as described in the Issuer’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on June 5, 2023, as supplemented, the Reporting Person received Common Stock of the Issuer as consideration for the common units of Longevity Market Assets, LLC and Abacus Settlements, LLC. On October 13, 2023, a transfer of 700,500 shares of Common Stock was made by the Reporting Person to East Sponsor, LLC to reflect the intended allocation of shares of Common Stock among the parties to the Merger Agreement, thereby reducing Reporting Person’s stated beneficial ownership from 13,293,750 to 12,593,250 of Common Stock.

     

      (d)

    Not applicable.

     

      (e)

    Not applicable.

     

    Item 6.

    Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

    None.

     

    Item 7.

    Material to be Filed as Exhibits.

     

    Exhibit B    Transfer Agreement between Jay Jackson, Todd Sean McNealy, Kevin Scott Kirby, Matthew A. Ganovsky, and East Sponsor, LLC dated October 13, 2023.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    October 20, 2023

     

    By:  

    /s/ Jay Jackson

    Name:   Jay Jackson
    Get the next $ERES alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ERES

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ERES
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Jackson Jay J

    4 - Abacus Life, Inc. (0001814287) (Issuer)

    2/15/24 9:03:41 PM ET
    $ERES
    Investment Managers
    Finance

    SEC Form 4 filed by Mccauley William Hugh Jr

    4 - Abacus Life, Inc. (0001814287) (Issuer)

    2/15/24 9:00:58 PM ET
    $ERES
    Investment Managers
    Finance

    SEC Form 4 filed by Kirby Kevin Scott

    4 - Abacus Life, Inc. (0001814287) (Issuer)

    2/15/24 8:58:21 PM ET
    $ERES
    Investment Managers
    Finance

    $ERES
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    East Resources Acquisition Company and Abacus Life Announce Completion of Business Combination

    ERES Shareholders Approved the Business Combination on June 29, 2023 Abacus Life to begin trading on Nasdaq on July 5, 2023 under ticker symbol "ABL" East Resources Acquisition Company (NASDAQ:ERES) ("ERES"), a publicly traded special purpose acquisition company, today announced the completion of its business combination with Abacus Life, a leading buyer of life insurance policies and a vertically integrated alternative asset manager specializing in specialty insurance products. ERES shareholders voted to approve the business combination at a meeting held on June 29, 2023. In connection with the completion of the business combination, ERES has been renamed "Abacus Life, Inc." ("Abacus

    7/3/23 8:00:00 AM ET
    $ERES
    Investment Managers
    Finance

    Abacus Life to Participate in Fireside Chat with IPO Edge and The Palm Beach Hedge Fund Association Friday, June 23 at 9:00am ET

    Abacus Settlements, LLC (d/b/a Abacus Life) and Longevity Market Assets, LLC (together "Abacus" or the "Company"), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, will participate in a virtual fireside chat with The Palm Beach Hedge Fund Association and IPO Edge Friday, June 23, 2023 at 9:00am ET. The live event will feature Abacus President and CEO, Jay Jackson and will be moderated by IPO Edge Editor-in-Chief John Jannarone who will discuss: Abacus' business combination with East Resources Acquisition Company (NASDAQ:ERES); Current ownership structure and growth story; Abacus' business

    6/22/23 8:00:00 AM ET
    $ERES
    Investment Managers
    Finance

    Abacus Life Continues to Expand Market Share in Life Settlement Payouts

    Abacus Pays 11% More per Policy Than its Closest Competitor Abacus Settlements, LLC (d/b/a Abacus Life) and Longevity Market Assets, LLC (together "Abacus" or the "Company"), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, announced today that according to financial publication The Deal, the Company continued to expand its market share in the life settlement industry and remained a leader in life settlement payouts in 2022, bringing premier value to its clients. The Deal report evaluates life settlement providers based on the number of policies purchased and value. For 2022, while the life settl

    6/15/23 2:11:00 PM ET
    $ERES
    Investment Managers
    Finance

    $ERES
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Gusky Adam Samuel bought $74,481 worth of shares (12,200 units at $6.10), increasing direct ownership by 116% to 22,718 units (SEC Form 4)

    4 - Abacus Life, Inc. (0001814287) (Issuer)

    11/20/23 6:57:24 PM ET
    $ERES
    Investment Managers
    Finance

    Mcnealy Sean bought $1,851 worth of shares (300 units at $6.17), increasing direct ownership by 0.00% to 12,593,550 units (SEC Form 4)

    4 - Abacus Life, Inc. (0001814287) (Issuer)

    11/20/23 6:15:43 PM ET
    $ERES
    Investment Managers
    Finance

    $ERES
    Financials

    Live finance-specific insights

    View All

    Abacus Life, a Leading Buyer of Life Insurance Policies and Vertically Integrated Alternative Asset Manager, to Become Public Company

    - Abacus Life and East Resources Acquisition Company (NASDAQ:ERES) enter business combination agreement - Sector leader within an uncorrelated alternative asset class with a $233 billion TAM, institutional investment grade counterparts and outsized growth potential, underpinned by steady financial performance - Proprietary technology platform yields differentiated underwriting capabilities - Transaction implies pro-forma enterprise value of $618 million; proceeds to be used to reduce cost of capital, scale hold portfolio and begin securitizing policy portfolios - Anticipated transaction close as early as the fourth quarter of 2022 - Combined company's shares of common stock expected to

    8/30/22 6:30:00 AM ET
    $ERES
    Investment Managers
    Finance

    $ERES
    Leadership Updates

    Live Leadership Updates

    View All

    Abacus Life Appoints New Managing Director

    Abacus Settlements, LLC (d/b/a Abacus Life) and Longevity Market Assets, LLC (together "Abacus" or the "Company"), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, today announced that Nicholas Sawuk has joined the Company as Managing Director. Sawuk brings nearly 20 years of experience in financial services and life settlements and has worked for companies such as a European Life Settlement Fund with its own life settlement provider, as well as Cantor Fitzgerald on Cantor Insurance Group's life settlement and insurance-linked securities desk in New York. Most recently, Sawuk served as the of Head

    6/8/23 4:15:00 PM ET
    $ERES
    Investment Managers
    Finance

    $ERES
    SEC Filings

    View All

    East Resources Acquisition Company filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Abacus Life, Inc. (0001814287) (Filer)

    2/15/24 4:56:14 PM ET
    $ERES
    Investment Managers
    Finance

    East Resources Acquisition Company filed SEC Form 8-K: Leadership Update

    8-K - Abacus Life, Inc. (0001814287) (Filer)

    2/15/24 4:54:23 PM ET
    $ERES
    Investment Managers
    Finance

    East Resources Acquisition Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Abacus Life, Inc. (0001814287) (Filer)

    2/15/24 4:51:51 PM ET
    $ERES
    Investment Managers
    Finance

    $ERES
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by East Resources Acquisition Company (Amendment)

    SC 13G/A - Abacus Life, Inc. (0001814287) (Subject)

    2/13/24 2:13:50 PM ET
    $ERES
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by East Resources Acquisition Company (Amendment)

    SC 13G/A - Abacus Life, Inc. (0001814287) (Subject)

    2/12/24 4:48:07 PM ET
    $ERES
    Investment Managers
    Finance

    SEC Form SC 13D/A filed by East Resources Acquisition Company (Amendment)

    SC 13D/A - Abacus Life, Inc. (0001814287) (Subject)

    10/20/23 4:37:06 PM ET
    $ERES
    Investment Managers
    Finance